← back to search

Chengcheng Zhang

Second Military Medical University · CN
Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Peptidase Inhibition and Analysis, Gut microbiota and health, and Medical Imaging Techniques and Applications.
h-index
37
citations
5,651
works
281
NIH funding
primary concept
email

Recent publications

Unraveling the synergy of dual heteroatom dopants in quantum dots for boosting photocatalytic CO2 reduction
Journal of Catalysis 2025cited by 2position: middledoi
A Novel tsRNA, m<sup>7</sup>G‐3′ tiRNA Lys<sup>TTT</sup>, Promotes Bladder Cancer Malignancy Via Regulating ANXA2 Phosphorylation
Advanced Science 2024cited by 26position: middledoi
NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression
Advanced Science 2024cited by 17position: middledoi
Enhancing m6A modification of lncRNA through METTL3 and RBM15 to promote malignant progression in bladder cancer
Heliyon 2024cited by 15position: middledoi
Active post-transcriptional regulation and ACLY-mediated acetyl-CoA synthesis as a pivotal target of Shuang-Huang-Sheng-Bai formula for lung adenocarcinoma treatment
Phytomedicine 2023cited by 16position: middledoi
YBX1‐Mediated DNA Methylation‐Dependent <i>SHANK3</i> Expression in PBMCs and Developing Cortical Interneurons in Schizophrenia
Advanced Science 2023cited by 9position: middledoi
FGFR1 variants contributed to families with tooth agenesis
Human Genomics 2023cited by 8position: middledoi
Identification of novel proteins for lacunar stroke by integrating genome-wide association data and human brain proteomes
BMC Medicine 2022cited by 55position: firstdoi
Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy
PLoS Pathogens 2022cited by 25position: middledoi
Development of an HiBiT‐tagged reporter H3N2 influenza A virus and its utility as an antiviral screening platform
Journal of Medical Virology 2022cited by 17position: firstdoi
Comprehensive and integrative analyses identify TYW5 as a schizophrenia risk gene
BMC Medicine 2022cited by 11position: firstdoi
H<sub>3</sub>TPAN-Triazole-Bn-NH<sub>2</sub>: Tripicolinate Clicked-Bifunctional Chelate for [<sup>225</sup>Ac]/[<sup>111</sup>In] Theranostics.
2022cited by 11position: contributordoi
[<sup>213</sup>Bi]Bi<sup>3+</sup>/[<sup>111</sup>In]In<sup>3+</sup>-neunpa-cycMSH: Theranostic Radiopharmaceutical Targeting Melanoma─Structural, Radiochemical, and Biological Evaluation.
2022cited by 11position: contributordoi
H<sub>4</sub>picoopa─Robust Chelate for <sup>225</sup>Ac/<sup>111</sup>In Theranostics.
2022cited by 10position: contributordoi
High-Contrast CXCR4-Targeted <sup>18</sup>F-PET Imaging Using a Potent and Selective Antagonist.
2021cited by 25position: contributordoi
Caspase‐3‐mediated GSDME activation contributes to cisplatin‐ and doxorubicin‐induced secondary necrosis in mouse macrophages
Cell Proliferation 2019cited by 73position: middledoi
Fluorescent Isoindole Crosslink (FlICk) Chemistry: A Rapid, User-friendly Stapling Reaction.
2019cited by 44position: contributordoi
A Metal-Free DOTA-Conjugated <sup>18</sup>F-Labeled Radiotracer: [<sup>18</sup>F]DOTA-AMBF<sub>3</sub>-LLP2A for Imaging VLA-4 Over-Expression in Murine Melanoma with Improved Tumor Uptake and Greatly Enhanced Renal Clearance.
2019cited by 24position: contributordoi
[<sup>68</sup>Ga]Ga/[<sup>177</sup>Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4.
2019cited by 21position: contributordoi
miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3
Oncology Letters 2017cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

François Bénard · University College London7 papers (2019–2022) · 6 papers (2019–2022) · 6 papers (2019–2022)Kuo-Shyan Lin · Brookhaven National Laboratory5 papers (2019–2022)Luke Wharton · TRIUMF3 papers (2022–2022)Chris Orvig · Massachusetts Institute of Technology3 papers (2022–2022)Cristina Rodríguez-Rodríguez · Vancouver Biotech (Canada)3 papers (2022–2022)Paul Schaffer · TRIUMF3 papers (2022–2022)Hua Yang · TRIUMF3 papers (2022–2022)Tao Li · Tsinghua University3 papers (2022–2023)Mingrui Liu · Dongguan University of Technology2 papers (2024–2024)Baotong Yang · Shanxi Agricultural University2 papers (2024–2024)Xiangdong Du · Shihezi University2 papers (2022–2022)Xiaojing Lin · University of Arizona2 papers (2022–2022)Wenyu Hu · Sun Yat-sen University2 papers (2024–2024)Wei Deng · Allen Institute for Brain Science2 papers (2022–2023)Qinghua Cui · University of Illinois Chicago2 papers (2022–2022)Yapeng Huang · Jiangxi University of Traditional Chinese Medicine2 papers (2024–2024)David M. Perrin · American Chemical Society2 papers (2019–2021)Lijun Rong · University of Illinois Chicago2 papers (2022–2022)